EPE Special Opps Ltd - Net Asset Value(s)
RNS Number : 6847V
EPE Special Opportunities Limited
10 April 2019
 

EPE Special Opportunities Limited

 

Net Asset Value

 

 

Subsequent to the release on 9 April 2019 of the EPE Special Opportunities Limited ("ESO", or the "Company") annual report and accounts for the year ended 31 January 2019, the Directors note the concurrent release of Luceco plc's annual report and accounts for the year ended 31 December 2018.

As previously disclosed, any change in the share price of Luceco plc will impact the ESO Net Asset Value.

At close of markets on 9 April 2019, the share price of Luceco plc was 77.80 pence per ordinary share which implied an estimated ESO Net Asset Value of 232.80 pence per ordinary share.

The Net Asset Value of ESO at 30 April 2019 will be confirmed in due course.

 

Enquiries:

 

EPIC Private Equity LLP

+44 (0) 207 269 8865

Alex Leslie



R&H Fund Services (Jersey) Limited

+44 (0) 1534 825 323

Hilary Jones



Cardew Group Limited

+44 (0) 207 930 0777

Richard Spiegelberg



Numis Securities Limited

+44 (0) 207 260 1000

Nominated Advisor:

Stuart Skinner / Hugh Jonathan

Corporate Broker:

Charles Farquhar

 

Disclaimer: This valuation, which has been prepared in good faith by the Company's Investment Adviser, is for information purposes only. It is derived from unaudited estimated valuations of the Company's underlying investments based on information received by the Investment Adviser which may relate to dates or periods some time before the date of this valuation. Such estimates may be subject to little verification or other due diligence and may not comply with generally accepted accounting practices or other generally accepted valuation principles. If a valuation estimate subsequently proves to be incorrect, no adjustment is expected to be made to any previously published estimated net asset value.


This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVUGUMUCUPBGRB ]]>